Biomedical Science and Clinical Research(BSCR)
ISSN: 2835-7914 | DOI: 10.33140/BSCR
Impact Factor: 1.7
Kang-ting Liao
Hansford Corporation, Beitun Dist., Taichung City, Taiwan
Publications
-
Original article
Wheat Gluten Hydrolyzed Peptide Protection Joint Osteoarthritis: A Randomized, Double-Blind, Placebo-Controlled Clinical Study
Author(s): Kang-ting Liao, Wei-Ting Hsieh, Yi-ming Liu, Dian-Hong Shen and Yu-Chin Lin*
Background: Osteoarthritis is the most predominant joint disease, that has obsession millions of people. The purpose of this study was to evaluate the efficacy from natural plant source purifying the hydrolyzed wheat peptides (Vollapep2TM) for knee osteoarthritis (OA) pain and associated symptoms compared to placebo group. Methods: The assessed have the change of Visual Analogue Scale (VAS) score, Western Ontario McMaster Osteoarthritis Index (WOMAC) and Traditional Chinese Medicine (TCM) syndrome classification, from baseline through 45 days between the Vollapep2TM and placebo groups. Results: At 45 days, the Vollapep2TM group demonstrated a significant reduction in VAS score compared to placebo group. Supplementation with Vollapep2TM also resulted in significant changes for all three WOMAC subscales: pain the Vol.. Read More»